Drug General Information (ID: DDIOIAMDWU)
Drug Name			Heparin		Drug Info		Cilostazol		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Anticoagulants				Vasodilator Agents
Structure

Mechanism of Heparin-Cilostazol Interaction (Severity Level: Minor)
Increased risk of bleeding Click to Show/Hide Mechanism Graph
Drug Name		Heparin				Cilostazol
Mechanism		Risk of bleeding Anticoagulant				Risk of bleeding Antiplatelet
Key Mechanism Factor 1
		Factor Name		Bleeding
		Factor Description		Patients may be at risk for bleeding when the outcome of a disease or disease treatment confounds the standard mechanisms for maintaining hemostasis. Signs or symptoms of abnormal bleeding include: bleeding that takes a long time to stop (including nosebleeds, bleeding gums, bleeding from cuts and abrasions, and menstrual bleeding); severe unexplained bruising, or bruising that becomes larger; blood in the urine or stool, etc.
Mechanism Description		Increased risk of bleeding by the combination of Heparin and Cilostazol

References
1	Product Information. Heparin Sodium (heparin). Lilly, Eli and Company, Indianapolis, IN.